Health & Medical Archives | Be Korea-savvy

Archive by category Health & Medical

Fresenius Medical Care Launches 4008A Dialysis Machine in India

Fresenius Medical Care Launches 4008A Dialysis Machine in India

India, Jan. 18 (Korea Bizwire) — Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced the launch of its 4008A dialysis machine, which was especially designed to meet the needs of emerging markets. With the launch of the 4008A, the company is aiming to improve accessibility to life-sustaining dialysis treatment [...]

Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station

Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station

RENSSELAER, N.Y., Jan. 17 (Korea Bizwire) — Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station.  This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support [...]

Nanobiotix Plans to Conduct Registered Public Offering in the United States

Nanobiotix Plans to Conduct Registered Public Offering in the United States

Paris, France and Cambridge, Massachusetts, Jan. 16 (Korea Bizwire) – NANOBIOTIX SA (Euronext : NANO – ISIN : FR0011341205) announced today that it plans to conduct a registered public offering of its ordinary shares, including in the form of American Depositary Shares (ADSs) in the United States, and has confidentially submitted a draft registration statement [...]

SLN124 Granted Orphan Drug Designation by EMA for the Treatment of β-Thalassemia

SLN124 Granted Orphan Drug Designation by EMA for the Treatment of β-Thalassemia

London, Jan. 15 (Korea Bizwire) – Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, announces that its lead medicine candidate SLN124 has been granted Orphan Drug Designation by the Committee for Orphan Medicinal Products (COMP), the [...]

TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial

TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial

EDMONTON, Alberta, Jan. 14 (Korea Bizwire) — Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO Chairman/Executive Director and Director of Clinical Translational Research at the University of California, Los Angeles Jonsson Comprehensive Cancer Center, announces enrollment of the first patient into its newest clinical [...]

HR Thought Leader Josh Bersin Joins Virgin Pulse CEO Advisory Board

HR Thought Leader Josh Bersin Joins Virgin Pulse CEO Advisory Board

PROVIDENCE, R.I., Jan. 8 (Korea Bizwire) — Virgin Pulse, the largest global employee health and wellbeing company, today announced that renowned HR technology analyst and influencer Josh Bersin, has joined Virgin Pulse’s CEO Advisory Board. In this capacity, Bersin will collaborate with Virgin Pulse CEO, David Osborne, and senior Virgin Pulse leaders to expand awareness [...]

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Zug, Switzerland, Jan. 8 (Korea Bizwire) - Lupin is pleased to announce that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders. Non-dystrophic myotonic disorders are a group of rare, inherited neuromuscular disorders which cause the inability to relax muscles following voluntary contraction. NaMuscla® [...]

Nanobiotix and MD Anderson Cancer Center Announce a Large-scale, Comprehensive Clinical Collaboration on NBTXR3

Nanobiotix and MD Anderson Cancer Center Announce a Large-scale, Comprehensive Clinical Collaboration on NBTXR3

Paris, France, Cambridge, Massachusetts (USA) and Houston, Texas (USA), Jan. 7 (Korea Bizwire) – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205) and The University of Texas MD Anderson Cancer Center today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers. [...]

Fertin Pharma Acquires Tab Labs – Provides the Combined Group a Unique CDMO Position in the North American Dietary Supplement Market

Fertin Pharma Acquires Tab Labs – Provides the Combined Group a Unique CDMO Position in the North American Dietary Supplement Market

VEJLE, Denmark, Jan. 7 (Korea Bizwire) — Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of Tab Labs Inc. (“Tab Labs”), a leader in compressed gum and mints / lozenges and one of the largest contracts tableting companies in North America servicing customers within Nutraceuticals as well as Confectionery. Headquartered in Vejle, [...]

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder

NEW YORK, Jan. 7 (Korea Bizwire) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that AXS-05, a novel, oral, investigational NMDA receptor antagonist with multimodal activity, met the prespecified primary endpoint and significantly improved symptoms of depression in the [...]